1. Apolipoprotein E knockout mice as a model of behavioral dysfunction

   • Illana Gozes

   Editorial Article Pages: 149 - 150

2. Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

   • Lorenzo M. Refolo
   • Howard M. Fillit

   Original Article Pages: 151 - 155

3. APOE genotype effects on alzheimer’s disease onset and epidemiology

   • J. Wesson Ashford

   Original Article Pages: 157 - 165

4. ApoE-dependent plasticity in Alzheimer’s disease

   • Bruce Teter

   Original Article Pages: 167 - 179

5. Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer’s disease

   • Keith A. Crutcher

   Original Article Pages: 181 - 188

6. Apolipoprotein E

   • Yadong Huang
   • Karl H. Weisgraber
   • Robert W. Mahley

   Original Article Pages: 189 - 204

7. A dual role for apolipoprotein E in neuroinflammation

   • Ling Guo
   • Mary Jo LaDu
   • Linda J. Van Eldik

   Original Article Pages: 205 - 212

8. Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease

   • Steven D. Edland

   Original Article Pages: 213 - 217

9. Cholesterol efflux as a critical component of Alzheimer’s disease pathogenesis

   • G. William Rebeck

   Original Article Pages: 219 - 224

10. Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene

    • Debomoy K. Lahiri

    Original Article Pages: 225 - 233

11. ApoE and Aβ1–42 interactions

    • Arlene M. Manelli
    • W. Blaine Stine
    • Mary Jo LaDu

    Original Article Pages: 235 - 246

12. In vivo effects of apoE and clusterin on amyloid-β metabolism and neuropathology

    • David M. Holtzman

    Original Article Pages: 247 - 254

13. Apolipoprotein E dose-dependent modulation of β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease

    • Ronald B. DeMattos

    Original Article Pages: 255 - 262